The market price of a stock at a given time is often not indicative of its true value. Ask any judge presiding over appraisal cases.
When and if sales of myCadian occur and a recurring revenue stream of Cura is demonstrated, and the growth curve for these revenues becomes manifest, the market will have some tangible data points to begin valuing this stock in a better way.
Right now IMO the stock is still being pervasively short manipulated.
Sales of myCadian are expected to begin by June, as represented by CRGS in SEC filings and CEO updates. That these representations have been made is a fact.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.